Case Report: Brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.

IF 2.3 4区 医学 Q3 ONCOLOGY
Zita Reisz, Bence Laszlo Radics, Peter Nemes, Ross Laxton, Laszlo Kaizer, Krisztina Mita Gabor, Timea Novak, Pal Barzo, Safa Al-Sarraj, Istvan Bodi
{"title":"Case Report: Brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.","authors":"Zita Reisz,&nbsp;Bence Laszlo Radics,&nbsp;Peter Nemes,&nbsp;Ross Laxton,&nbsp;Laszlo Kaizer,&nbsp;Krisztina Mita Gabor,&nbsp;Timea Novak,&nbsp;Pal Barzo,&nbsp;Safa Al-Sarraj,&nbsp;Istvan Bodi","doi":"10.3389/pore.2023.1611231","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Angiocentric gliomas (AG) in brainstem location are exceedingly rare and might cause differential diagnostic problems and uncertainty regarding the best therapeutic approach. Hereby, we describe the clinicopathological findings in a brainstem AG presenting in a toddler child and review the literature. <b>Case report:</b> A 2-year-old boy presented with 5 weeks history of gait disturbances, frequent falls, left-sided torticollis and swallowing problems. MRI head showed a T2-hyperintense, partly exophytic mass lesion centred in the pontomedullary region, raising the possibility of diffuse midline glioma. The exophytic component was partially resected by suboccipital craniotomy, leaving intact the infiltrative component. Ventriculoperitoneal shunt was implanted due to postoperative hydrocephalus. Histological examination revealed a moderately cellular tumour consisted of bland glial cells infiltrating the brain parenchyma and radially arranged around the blood vessels. By immunohistochemistry, the tumour strongly expressed S100 and GFAP in addition to intense nestin positivity, while OLIG2 was negative in the perivascular tumour cells. DNA methylation array profiled the tumour as \"methylation class diffuse astrocytoma, <i>MYB</i> or <i>MYBL1</i>-altered subtype B (infratentorial)\" and an in-frame <i>MYB::QKI</i> fusion was identified by RNA sequencing, confirming the diagnosis of angiocentric glioma. The patient has been initially treated with angiogenesis inhibitor and mTOR inhibitor, and now he is receiving palliative vinblastine. He is clinically stable on 9 months follow-up. <b>Conclusion:</b> Brainstem AG may cause a diagnostic problem, and the surgical and oncological management is challenging due to unresectability and lack of response to conventional chemo-radiation. In the future, genetically-tailored therapies might improve the prognosis.</p>","PeriodicalId":19981,"journal":{"name":"Pathology & Oncology Research","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287963/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology & Oncology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/pore.2023.1611231","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Angiocentric gliomas (AG) in brainstem location are exceedingly rare and might cause differential diagnostic problems and uncertainty regarding the best therapeutic approach. Hereby, we describe the clinicopathological findings in a brainstem AG presenting in a toddler child and review the literature. Case report: A 2-year-old boy presented with 5 weeks history of gait disturbances, frequent falls, left-sided torticollis and swallowing problems. MRI head showed a T2-hyperintense, partly exophytic mass lesion centred in the pontomedullary region, raising the possibility of diffuse midline glioma. The exophytic component was partially resected by suboccipital craniotomy, leaving intact the infiltrative component. Ventriculoperitoneal shunt was implanted due to postoperative hydrocephalus. Histological examination revealed a moderately cellular tumour consisted of bland glial cells infiltrating the brain parenchyma and radially arranged around the blood vessels. By immunohistochemistry, the tumour strongly expressed S100 and GFAP in addition to intense nestin positivity, while OLIG2 was negative in the perivascular tumour cells. DNA methylation array profiled the tumour as "methylation class diffuse astrocytoma, MYB or MYBL1-altered subtype B (infratentorial)" and an in-frame MYB::QKI fusion was identified by RNA sequencing, confirming the diagnosis of angiocentric glioma. The patient has been initially treated with angiogenesis inhibitor and mTOR inhibitor, and now he is receiving palliative vinblastine. He is clinically stable on 9 months follow-up. Conclusion: Brainstem AG may cause a diagnostic problem, and the surgical and oncological management is challenging due to unresectability and lack of response to conventional chemo-radiation. In the future, genetically-tailored therapies might improve the prognosis.

Abstract Image

Abstract Image

病例报告:出现在蹒跚学步儿童的脑干血管中心性胶质瘤——诊断和治疗的挑战。
脑干部位的血管中心性胶质瘤(AG)极为罕见,可能导致鉴别诊断问题和最佳治疗方法的不确定性。在此,我们描述的临床病理结果在脑干AG呈现在一个学步儿童和回顾文献。病例报告:一名2岁男孩,表现为5周的步态障碍,频繁跌倒,左侧斜颈和吞咽问题。MRI头部显示t2高信号,部分外生性肿块以桥脑髓区为中心,增加弥漫性中线胶质瘤的可能性。通过枕下开颅术部分切除外生性成分,保留浸润性成分。由于术后脑积水,植入脑室腹腔分流器。组织学检查显示为中度细胞性肿瘤,由浸润脑实质的淡色胶质细胞组成,呈放射状排列在血管周围。免疫组化结果显示,肿瘤除巢蛋白(nestin)阳性外,S100和GFAP表达强烈,而血管周围肿瘤细胞中OLIG2表达阴性。DNA甲基化阵列将肿瘤描述为“甲基化级弥漫性星形细胞瘤,MYB或mybl1改变亚型B(幕下)”,通过RNA测序鉴定框架内MYB::QKI融合,证实了血管中心性胶质瘤的诊断。患者最初接受血管生成抑制剂和mTOR抑制剂治疗,现在接受姑息性长春碱治疗。随访9个月,临床稳定。结论:脑干AG可能引起诊断问题,由于其不可切除性和对常规放化疗缺乏反应,手术和肿瘤治疗具有挑战性。在未来,基因定制疗法可能会改善预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
134
审稿时长
4-8 weeks
期刊介绍: Pathology & Oncology Research (POR) is an interdisciplinary Journal at the interface of pathology and oncology including the preclinical and translational research, diagnostics and therapy. Furthermore, POR is an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments on the selected biomedical fields bridging the gap between basic research and clinical medicine. It is a special aim for POR to promote pathological and oncological publishing activity of colleagues in the Central and East European region. The journal will be of interest to pathologists, and a broad range of experimental and clinical oncologists, and related experts. POR is supported by an acknowledged international advisory board and the Arányi Fundation for modern pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信